Clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other ocular diseases caused by oxidative stress.

Fort Worth, Texas
Joined August 2022
Follow our progress in developing innovative treatments for #oxidativestress, a driver of blinding #eyediseases and other conditions. Currently, we are advancing our treatments for #retinitispigmentosa, #cataract, and cystinosis with key backing from @FightBlindness’ @RD_Fund 👁️
1
3
1
15
Understanding the realities of #visionloss is key to fighting for a more accessible world. @FightBlindness' Vision Viewer simulates how retinal diseases affect vision. Visit fightingblindness.org/sharey… and join us to honor the visually impaired community for #BlindnessAwarenessMonth.
1
11
#AAO2026 is underway! As we develop #oxidativestress therapies for blinding eye diseases, we’re looking forward to connecting with the global #ophthalmology community and learning ways to collectively advance new approaches for patients.
Experience the impact at #AAO2026 in New Orleans, Oct. 9-12! Gain hands-on learning, connect with ophthalmologists worldwide, and celebrate New Orleans style at Illuminate. Don’t miss your opportunity to save on registration before rates increase on Sept. 10: aao.org/register #AAO #Ophthalmology
1
91
#WorldSightDay is about highlighting eye health and the important role it plays in preventing vision loss. Join the millions who have made the pledge to #LoveYourEyes and contribute to a movement to preserve sight globally:  iapb.world/make_a_pledge #EyeHealth #VisionLoss
World Sight Day 2026 is only 100 days away! On 8 Oct, #WorldSightDay puts the power of people at the heart of the campaign, stories, lived experiences and voices driving action for eye health. Learn more: brnw.ch/21x3MtV #LoveYourEyes #EveryStoryCounts #2030InSight
1
22
Attending #Euretina26? Dr. Fred Chen is presenting an ePoster highlighting our clinical data in #RP associated with #UsherSyndrome. Learn more: euretina.org #USH #retina
34
Save the Date: #Euretina26: Oct. 1 – 4, 2026, in Vienna, Austria. Dr. Fred Chen will present an ePoster highlighting our clinical data in #RP associated with #UsherSyndrome. Learn more: euretina.org/ #USH #retina
1
44
Encouraging progress in #UsherSyndrome research. In a new research update, @FightBlindness highlights advances across the field, including our Phase 3 SLO-RP Preserve trial evaluating NPI-001 in people with RP associated with Usher syndrome. Read more: fightingblindness.org/news/u…
2
46
Usher syndrome (#USH) is a leading cause of #deafblindness. For #UsherSyndrome Awareness Day we’re spotlighting this rare, inherited disease and the community surrounding it. Learn more about Nacuity’s clinical program for #visionloss in USH patients: preservevisionstudy.com/
13
The first site in the SLO-RP Preserve Phase 3 #clinicaltrial is enrolling at the @RetinaFndation in Dallas, TX! This global, confirmatory #clinicaltrial is evaluating NPI-001 for #RetinitisPigmentosa associated w/#UsherSyndrome. Learn more at preservevisionstudy.com.
1
61
Heading to #USH2026? Join us at the @UsherCoalition USH Connections Conference, where our CCO & SVP, Jami Kern, will share an update on NPI-001 and participate in a research panel. 📍July 18 | 11:15 a.m. CDT Learn more: usher-syndrome.org/ush2026/a…
30
We are proud to sponsor the @UsherCoalition USH Connections Conference 2026, taking place July 17-19 in Bloomington, MN. Our CCO & SVP, Jami Kern, will present an update on NPI-001 to treat #RetinitisPigmentosa due to USH. Learn more: usher-syndrome.org/ush2026/a…
2
122
This #DeafBlindAwarenessWeek, we recognize the strength and resilience of the #deafblind community and reflect on the challenges they face. We desire to create an accessible world for all. #DBAW26
1
17
Exciting news for the #InheritedRetinalDisease community! Thanks @RaceVsBlindness for helping advance gene-agnostic therapeutic approaches, including our clinical development efforts in #RetinitisPigmentosa, and to @FightBlindness and @RD_Fund for their commitment to patients.
1
40
June is #CataractAwarenessMonth. #Cataracts remain a leading cause of blindness affecting ~65M people worldwide. Our investigational intravitreal implant is designed to slow cataracts after vitrectomy and improve surgical outcomes. Learn more: nacuity.com/development-prog…
15
This week is #UnitedInVision 2026 in our home city of Fort Worth, TX, June 12-13, 2026. Don’t miss Nacuity SVP & CCO Dr. Jami Kern presenting. Details: fightingblindness.org/vision… We look forward to a weekend of hope, innovation, and connection!
15
The Nacuity leadership team joined the global #ARVO2026 eye & vision community to present and engage in scientific sessions and discussions w/ researchers and orgs like @FightBlindness on the future of vision science. We're inspired by the progress across eye and vision research!
2
26
Attending #ARVO2026? Don’t miss our poster on NPI-001 tablets targeting #OxidativeStress to treat #RetinitisPigmentosa associated with #UsherSyndrome. 📍 Poster #0632 🔬 Session 512 (IRD II) 🗓 May 7 | 8:00–9:45 AM
106
Join our SVP & CCO, Dr. Jami Kern, at the #ARVO2026 "Bench to Bedside” pre-session on May 2 | 8 am - 2:45 pm MT to learn about our clinical progress and the path to IND for NACA for #retinitispigmentosa in the US and Australia. 🔗 arvo.org/annual-meeting/prog…
50
On National #DNA Day, we recognize the genetic research that has advanced #InheritedRetinalDisease treatment. 🧬 Genetic testing plays an important role in helping patients understand their diagnosis to get the care they need. Read more: @FightBlindness: fightingblindness.org/geneti…
1
15